—DVN
— • —
$47.79
P/E
11.44
PEG
—
FCF Yield
—
Rev Growth YoY
+783.0% YoY
Gross Margin
4646.0%
Health Score
4/10
D/E Ratio
0.54
Confidence
LOW
Business Snapshot
The ticker and exchange identifiers are absent from this payload, which significantly limits contextual analysis. Based on the available financial ratios — a P/E of 11.44x, Price/Sales of 1.73x, and reported revenue growth of 783% year-over-year — this appears to be a company in an early-to-mid growth phase. Without a confirmed market capitalisation figure, precise cap-tier classification is not possible, though the valuation multiples are consistent with a small- to mid-cap profile.
Financial Health
**Score: 4/10** The financial picture here is deeply unusual and warrants caution. Reported gross margins of 4,646% and a net margin of 1,537% are almost certainly the result of accounting anomalies, one-time items, or data distortions — figures of this magnitude are not operationally realistic for any conventional business...
Risk Assessment
- **DATA INTEGRITY:** Gross margin of 4,646% and net margin of 1,537% are statistically implausible for a normal operating business and suggest potential data errors, restatements, or one-time accounting events that distort the entire financial picture. - **EARNINGS DETERIORATION:** Earnings growth of -862% year-over-year directly contradicts the revenue growth narrative, signalling that costs, writedowns, or losses are accelerating faster than revenues. - **LIQUIDITY:** A current ratio of 0.98x means the company's short-term assets do not fully cover its short-term liabilities, leaving minimal financial buffer. - **CASH FLOW OPACITY:** Free cash flow is unavailable, making it impossible to validate reported profitability or assess the company's ability to self-fund operations and growth. - **TECHNICALS:** A confirmed death cross (50-day MA crossing below the 200-day MA), bearish MACD signal, and price positioned below both moving averages indicate negative price momentum across multiple timeframes. ---...